E3 PreliminaryPreliminaryPEM not requiredCross-SectionalPeer-reviewedReviewed
[Identification and application of marker genes for differential diagnosis of chronic fatigue syndrome].
Kawai, Tomoko, Rokutan, Kazuhito · Nihon rinsho. Japanese journal of clinical medicine · 2007
Quick Summary
This study looked for genetic markers (differences in how genes are expressed) that could help doctors diagnose ME/CFS with a blood test. The researchers identified 9 genes that were expressed differently in ME/CFS patients compared to healthy people, and showed these genes could potentially be used to distinguish ME/CFS from other conditions.
Why It Matters
ME/CFS currently lacks objective diagnostic biomarkers, requiring diagnosis through clinical criteria alone. Identifying reproducible gene expression markers could enable faster, more reliable diagnosis and help distinguish ME/CFS from other fatiguing illnesses, improving patient outcomes and research recruitment.
Observed Findings
- Nine genes showed significant differential expression between CFS patients and healthy controls
- Expression changes identified by microarray were confirmed using quantitative PCR validation
- These 9 genes demonstrated utility for differential diagnosis of CFS
- Gene expression profiles differed from previously reported studies and CDC cohort findings
- No single standardized set of genetic markers for CFS has emerged across studies
Inferred Conclusions
- Gene expression profiling may identify potential diagnostic markers for CFS
- Validation by quantitative PCR supports the feasibility of using these genes for diagnostic purposes
- The discrepancy between studies suggests CFS may involve heterogeneous genetic expression patterns or require larger, better-standardized studies
Remaining Questions
- Why do gene expression profiles differ so substantially between different CFS research groups, and what accounts for this lack of reproducibility?
- Are these 9 genes specific to CFS or do they also appear in other fatiguing conditions?
- Have these 9 genes been validated in independent patient cohorts, and do they maintain diagnostic utility across different populations?
What This Study Does Not Prove
This study does not prove these 9 genes cause ME/CFS or explain the biological mechanisms underlying the disease. The lack of overlap with other gene expression studies raises questions about whether these markers are reproducible across different patient populations and methodologies. The study cannot determine whether these expression changes are disease-specific or might occur in other conditions.
Tags
Symptom:Fatigue
Biomarker:Gene ExpressionBlood Biomarker
Method Flag:Weak Case DefinitionSmall SampleExploratory Only
Metadata
- PMID
- 17561693
- Review status
- Editor reviewed
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 12 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.